A new national health agenda: Providing the public with accurate information

Journal of Social Issues

Volumn 55, Issue 2, 1999, Pages 383-400

  Cogan, Jeanine C ^a,b,c  

^a SPSSI   (United States)

^b Off of Representative Diana DeGette   (United States)

^c AMERICAN PSYCHOLOGICAL ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003185433     PISSN: 00224537     EISSN: None     Source Type: Journal    
DOI: 10.1111/0022-4537.00122     Document Type: Article

References (57)

1. Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., Simonneau, G., & Begaud, B. (1996). Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Pulmonary Hypertenstion Study. New England Journal of Medicine, 335, 606-616.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association.
3. Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., Lin, P. H., & Karanja, N. (1997). A clinical trial of the effects of dietary patterns on blood pressure. New England Journal of Medicine, 336(16), 1117-1124.
4. Berg, F. M. (1995). Health risks of weight loss (3rd ed.) Hettinger, ND: Healthy Weight Journal.
5. Berg, F. M. (1997). Afraid to eat: Children and teens in weight crisis. Hettinger, ND: Healthy Weight Journal.
6. Biener, L., & Heaton, A. (1995). Women dieters or normal weight: Their motives, goals, and risks. American Journal of Public Health, 85, 714-717.
7. Bild, D. E., Sholinsky, P., Smith, D. E., Lewis, C. E., Hardin, J. M., & Burke, G. L. (1996). Correlates and predictors of weight loss in young adults: The CARDIA study. International Journal of Obesity and Related Metabolic Disorders, 20, 47-55.
8. Bliss, E. L., & Branch, C. H. (1960). Anorexia nervosa: Its history, psychology, and biology. New York: Paul B. Hoeber.
9. Brown, D. (1997, July 9). Two weight loss drugs linked to heart valve ills. The Washington Post, p. A01.
10. Center for Science in the Public Interest. (1996). Petition for proposed rulemaking to regulate the commercial weight-loss program industry. Submitted to the United States Federal Trade Commission, Washington, DC.
11. Cogan, J. C. (1999). Re-evaluating the weight-centered approach toward health: The need for a paradigm shift. In J. Sobal & D. Maurer (Eds.), Interpreting weight: The social management of fatness and thinness (pp. 229-254). New York: Aldine de Gruyter.
12. Colditz, G. A. (1992). Economic costs of obesity. American Journal of Clinical Nutrition, 55, 503S-507S.
13. Denis, P., Charpentier, D., Berros, P., & Touameur, S. (1995). Bilateral acute angle-closure glaucoma after dexfenfluramine treatment. Ophthalmolgica, 209, 223-224.
14. Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriation Bill, 1998, Union Calendar No. 126, 105th Congress, 1st Session (1997).
15. Ernsberger, P. (1987). NIH consensus conference on obesity: By whom and for what? Journal of Nutrition, 117, 1164-1165.
16. Ernsberger, P. (1997). Adverse reactions to dexfenfluramine. Healthy Weight Journal, 11, 6-9.
17. Ernsberger, P., & Haskew, P. (1987). Health implications of obesity: An alternative view. Journal of Obesity and Weight Regulation, 6, 58-137.
18. Ernsberger, P., & Koletsky, R. J. (1995). Weight cycling. Journal of the American Medical Association, 273, 998-999.
19. French, S. A., Jeffrey, R. W., Folsom, A. R., Williamson, D. F., & Byers, T. (1995). History of intentional and unintentional weight loss in a population-based sample of women aged 55 to 69 years. Obesity Research, 3, 163-170.
20. Gandour, M. J. (1984). Bulimia: Clinical description, assessment, etiology, and treatment. International Journal of Eating Disorders, 3, 3-38.
21. Garner, D. M. (1993). Pathogenesis of anorexia nervosa. Lancet, 341, 1631-1635.
22. Garner, D. M., & Wooley, S. C. (1991). Confronting the failure of behavioral and dietary treatments for obesity. Clinical Psychology Review, 11, 729-780.
23. Goodrick, G. K., & Foreyt, J. P. (1991). Why treatments for obesity don't last. Journal of the American Dietetic Association, 91, 1243-1247.
24. Griffiths, R., & Farnill, D. (1996). Primary prevention of eating disorders: An update. Journal of Family Studies, 2, 179-191.
25. Gurtner, H. P. (1985). Aminorex and pulmonary hypertension: A review. Cor Vasa, 27(2-3), 160-171.
26. Hanotin, C., Thomas, F., Jones, S. P., Leutenegger, E., & Drouin, P. (1998). Efficacy and tolerability of sibutramine in obese patients: A dose-ranging study. International Journal of Obesity, 22(1), 32-38.
27. Herzog, D.B. (1997). The prevalence and consequences of eating disorders and the importance of early detection. Paper presented at a congressional briefing cosponsored by the Society for the Psychological Study of Social Issues and the American Psychological Association, Washington, DC.
28. Herzog, D. B., & Copeland, P. M. (1985). Eating disorders. New England Journal of Medicine, 313, 295-303.
29. Institute of Medicine. (1995). Weighing the options: Criteria for evaluating weight-management programs. Washington, DC: National Academy Press.
30. Kramer, F. M., Jeffery, R. W., Forster, J. L., & Snell, M. K. (1989). Long-term follow-up for behavioral treatment for obesity: Patterns of weight regain among men and women. International Journal of Obesity, 13, 123-136.
31. Laessle, R. G., Platte, P., Schweiger, U., Pirke, K. M. (1996). Biological and psychological correlates of intermittent dieting behavior in young women: A model for bulimia nervosa. Physiology and Behavior, 60, 1-5.
32. Levitsky, D. (1997). Diet drugs gain popularity. Healthy Weight Journal, 11, 8-12.
33. Lissner, L., Odell, P. M., D'Agostino, R. B., Stokes, J. III, Kreger, B. E., Belanger, A. J., & Brownell, K. D. (1991). Variability of body weight and health outcomes in the Framingham population. New England Journal of Medicine, 324, 1839-1844.
34. Manson, J. E., & Faich, G. A. (1996). Pharmacotherapy for obesity - Do the benefits outweigh the risks? New England Journal of Medicine, 335, 659-660.
35. Manson, J. E., Willett, W. C., Stampfer, M. J., Colditz, G. A., Hunter, D. J., Hankinson, S. E., Hennekens, C. H., & Speizer, F. E. (1995). Body weight and mortality among women. New England Journal of Medicine, 333, 677-685.
36. Muls, E., Kempen, K., Vansant, G., & Saris, W. (1995). Is weight cycling detrimental to health? A review of the literature in humans, international Journal of Obesity and Related Metabolic Disorders, 19, S46-50.
37. Myers, J. E., Buysse, D. J., Thase, M. E., Perel, J., Miewald, J. M., Cooper, T. B., Kupfer, D. J., & Mann, J. J. (1993). The effects of fenfluramine on sleep and prolactin in depressed inpatients: A comparison of potential indices of brain serotonergic responsivity. Biological Psychiatry, 34(11), 753-758.
38. National Institutes of Health Consensus Development Conference Statement. (1985). Health implications of obesity. Annals of Internal Medicine, 103, 1073-1077.
39. National Institutes of Health National Task Force on the Prevention and Treatment of Obesity. (1994). Weight cycling. Journal of the American Medical Association, 272, 1196-1202.
40. Patton, G. (1992). Eating disorders: Antecedents, evolution and course. Annals of Medicine, 24, 281-285.
41. Polivy, J., & Herman, C. P. (1985). Dieting and bingeing: A causal analysis. American Psychologist, 40, 193-201
42. Reife, C. M. (1995). Involuntary weight loss. Med. Clin. North Am., 79, 299-313.
43. Schaefer, E. J., Lichtenstein, A. H., Lamon-Fava, S., McNamara, J. R., Schaefer, M. M., Rasmussen, H., & Ordovas, J. M. (1995). Body weight and low-density lipoprotein cholesterol changes after consumption of a low-fat ad libitum diet. Journal of the American Medical Association, 274, 1450-1455.
44. Shape Up America. (1996). Guidance for treatment of obesity. Washington, DC: American Obesity Association.
45. Shisslak, C. M., Crago, M., Neal, M. E., & Swain, B. (1987). Primary prevention of eating disorders. Journal of Consulting and Clinical Psychology, 55, 660-667.
46. Stock, M. J. (1997). Sibutramine: A review of the pharmacology of a novel antiobesity agent. International Journal of Obesity and Related Metabolic Disorders, 21(Suppl. 1).
47. Striegel-Moore, R. H., Silberstein, L. R., & Rodin, J. (1986). Toward an understanding of risk factors for bulimia. American Psychologist, 41, 246-263.
48. Striegel-Moore, R.H., Wifley, D., Pike, K. M., Dohm, F. A., & Fairburn, C. (1996, November). Eating disorder symptoms in Black American women: The New England Women 's Health Project. Paper presented at annual meeting of the Research Society for Eating Disorders, Pittsburgh, PA.
49. Stunkard, A. J., Harris, J. R., Pedersen, N. L., and McClearn, G. E. (1990). The body mass index of twins who have been reared apart. New England Journal of Medicine, 322, 1483-1487.
50. Stunkard, A. J., & McLaren-Hume, M. (1959). The results of treatment for obesity. Archives of Internal Medicine, 103, 79-85.
51. Stunkard, A. J., Sorensen, T. I., Hanis, C., Teasdale, T. W., Chakraborty, R., Schull, W. J., and Schulsinger, F. (1986). An adoption study of human obesity. New England Journal of Medicine, 314, 193-198.
52. Toornvliet, A. C., Pijl, H., & Meinders, A. E. (1994). Major depression during dexfenfluramine treatment. International Journal of Obesity and Related Metabolic Disorders, 18(9), 650.
53. Troiano, R. P., Frongillo, E. A. Jr., Sobal, J., & Levitsky, D. A. (1996). The relationship between body weight and mortality: A quantitative analysis of combined information from existing studies. International Journal of Obesity and Related Metabolic Disorders, 20, 63-75.
54. Waaler, H. T. (1984). Height, weight, and mortality: The Norwegian experience. Acta Medica Scandinavica, 679(Suppl.), 1-51.
55. Williamson, D. F. (1996). "Weight cycling" and mortality: How do the epidemiologists explain the role of intentional weight loss. Journal of the American College of Nutrition, 15, 6-13.
56. Wilson, G. T. (1994). Behavioral treatment of obesity: Thirty years and counting. Advances in Behaviour Research and Therapy, 16, 31-75.
57. Wolf, N. (1991). The beauty myth: How images of beauty are used against women. New York: William Morrow & Co.